Hyderabad based vaccine maker Bharat Biotech International Limited (BBIL) has in-licensed a potential vaccine candidate for ...

GSK said it licensed its Shigella vaccine candidate, altaltSonflex1-2-3, to Bharat Biotech International.

For the first time, Fortune analyzed the top companies across the continent in partnership with Statista to find the ...

Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Advent, a leading global private equity investor, today announced that funds managed by Advent have signed a definitive agreement to invest USD $175 million via primary and secondary for a significant ...

On April 22, 2025, a court released a decision favouring Al Meghji’s client. And while that’s hardly unusual for the Osler ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

There is more than one path to future supply chain success. Industry analyst group says company’s choice of strategic focus should dictate what tech it invests in. The industry analyst group Gartner ...

AbbVie ABBV expects to return to robust revenue growth in 2025, just two years after losing U.S. exclusivity for its flagship ...

Felix Pharma, a global leader in off-patent animal medicines, secures $175 million investment from Advent for expansion.

The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by rising vaccine uptake, impr ...